🇺🇸 FDA
Pipeline program

Conivaptan

087-CL-088

Approved small_molecule completed

Quick answer

Conivaptan for Hyponatremia is a Approved program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 4 ClinicalTrials.gov record(s).

Program details

Company
CUMBERLAND PHARMACEUTICALS INC
Indication
Hyponatremia
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials